PRVA Form 144: Affiliate sale notices

David Mountcastle filed a Form 144 reporting proposed sales of Common Stock of PRVA.

Accepted by SEC EDGAR 04/02/2026 - 04:58 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

David Mountcastle filed a Form 144 reporting proposed sales of Common Stock of PRVA. The filing lists multiple sale entries tied to open-market dispositions and a separate restricted stock vesting on 04/01/2026.

Reported sale examples include 5,361 shares on 02/26/2026 for $134,030.87 and 7,697 shares on 02/27/2026 for $192,798.08, with additional sales in March 2026.

Key Figures

Sale example 1: 5,361 shares Sale example 2: 7,697 shares Restricted vesting: 5,566 shares +2 more

5 metrics

Sale example 1 5,361 shares 02/26/2026 sale for $134,030.87

Sale example 2 7,697 shares 02/27/2026 sale for $192,798.08

Restricted vesting 5,566 shares Restricted Stock Vesting on 04/01/2026

Sale example 3 5,177 shares 03/06/2026 sale for $119,852.73

Sale example 4 6,565 shares 03/13/2026 sale for $141,309.66

Key Terms

Form 144, Restricted Stock Vesting, Issuer, Fidelity Brokerage Services LLC

4 terms

Form 144 regulatory

"filed a Form 144 reporting proposed sales of Common Stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting on 04/01/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Issuer financial

"Restricted Stock Vesting | Issuer | 5566 | 04/01/2026 | Compensation"

Fidelity Brokerage Services LLC other

"Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the PRVA Form 144 filed by David Mountcastle disclose?

It discloses proposed sales of Common Stock by David Mountcastle. The filing lists multiple sale transactions with dates and quantities, plus a restricted stock vesting entry dated 04/01/2026, showing specific share counts and gross proceeds for each trade.

How many PRVA shares did David Mountcastle sell in late February and March 2026?

The filing lists several transactions totaling multiple thousands of shares across Feb–Mar 2026. Examples include 5,361 shares (02/26/2026) and 7,697 shares (02/27/2026); additional March entries range from 5,177 to 6,565 shares per trade.

Does the Form 144 show any restricted stock activity for PRVA?

Yes — the filing lists a Restricted Stock Vesting on 04/01/2026. That entry is labeled as "Restricted Stock Vesting" with 5,566 shares and indicates the securities were issued by the issuer for compensation.

Are proceeds from the reported PRVA sales provided in the filing?

Yes, gross proceeds are listed for each sale line. Examples include $134,030.87 for 5,361 shares (02/26/2026) and $192,798.08 for 7,697 shares (02/27/2026); each transaction row shows the dollar amount associated with the shares sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001858396
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Privia Health Group, Inc.
SEC File Number	001-40365
Address of Issuer	950 N. GLEBE RD., SUITE 700 ARLINGTON VIRGINIA 22203
Phone	571-366-8850
Name of Person for Whose Account the Securities are To Be Sold	Mountcastle David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5566	116055.55	123688289	04/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2026	Restricted Stock Vesting	Issuer			5566	04/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	02/26/2026	5361	134030.87
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	02/27/2026	7697	192798.08
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/06/2026	5177	119852.73
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/09/2026	5829	133158.26
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/12/2026	6453	141317.47
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/13/2026	6565	141309.66
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/16/2026	6391	141303.73

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	04/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Mountcastle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)